Gantoner Mab - The Brain Bleed Trial

Marty had never before wanted to know his gean status. Did he want to find out whether he carried the jean and be able to take the medication, or did he want to leave the trial? Marty's positivity was justified. It wasn't all bad news. Participants taking gantonerimab might not have done better cognitively, but they showed brain changes that offered some hope. Ganton er mab was reversing amaloid plac build up, as well as reducing other impo an measures that would have indicated newre degeneration. Although those taking the drugs didn't show improved cognitive skills, they didn't show worsening ones either.